CRISPR Therapeutics AG

CRSP | NASDAQ

Price Alert Chart Builder DCF Calculator

$51.40

-$2.86 (-5.27%)

At close: Oct 30, 2026, 3:59 PM ET

$51.70

+$0.30 (+0.58%)

Pre-market: Nov 2, 2026, 8:03 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-581.6M	-366.25M	-153.61M	-650.18M	377.66M	-348.87M
Depreciation & Amortization	19.48M	19.26M	19.84M	24.17M	17.95M	9.18M
Stock-Based Compensation	72.5M	86.57M	81.03M	97.95M	102.39M	66.02M
Other Working Capital	1.99M	-18.73M	26.66M	14.38M	27.02M	33.49M
Other Non-Cash Items	72.73M	-38.62M	-14.05M	12.47M	14.11M	1.86M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	71.88M	156.27M	-193.59M	19.85M	26.86M	33.44M
Operating Cash Flow	-345.01M	-142.77M	-260.38M	-495.74M	538.97M	-238.37M
Capital Expenditures	-914K	-1.9M	-9.47M	-37.19M	-81.71M	-18.36M
Cash Acquisitions	n/a	n/a	n/a	221.47M	953.73M	522.81M
Purchase of Investments	-1.01B	-1.49B	-1.07B	-1.42B	-1.51B	-594M
Sales Maturities Of Investments	1.01B	1.21B	1.45B	1.2B	555.6M	71.19M
Other Investing Acitivies	-34M	n/a	-2.5M	-221.47M	-953.73M	-522.81M
Investing Cash Flow	-31.81M	-280.48M	374.65M	-258.66M	-1.04B	-541.17M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	31.29M	n/a	37.62M	37.68M	33.86M
Financial Cash Flow	426.03M	331.98M	62.66M	38.59M	250.95M	1.02B
Net Cash Flow	49.3M	-91.29M	177.59M	-715.88M	-245.52M	236.66M
Free Cash Flow	-345.93M	-144.68M	-269.85M	-532.93M	457.27M	-256.72M
Adj. Free Cash Flow	-418.43M	-231.24M	-350.87M	-630.88M	354.88M	-322.74M
Maintenance CapEx	-914K	-1.9M	n/a	-37.19M	n/a	-18.36M
Growth CapEx	n/a	n/a	-9.47M	n/a	-81.71M	n/a
Owner Earnings	-345.93M	-144.68M	-260.38M	-532.93M	538.97M	-256.72M